160 related articles for article (PubMed ID: 11099696)
21. Metabolic effects of troglitazone on fat-induced insulin resistance in the rat.
Khoursheed M; Miles PD; Gao KM; Lee MK; Moossa AR; Olefsky JM
Metabolism; 1995 Nov; 44(11):1489-94. PubMed ID: 7476339
[TBL] [Abstract][Full Text] [Related]
22. Troglitazone induces expression of PPARgamma in liver.
Davies GF; Khandelwal RL; Roesler WJ
Mol Cell Biol Res Commun; 1999; 2(3):202-8. PubMed ID: 10662598
[TBL] [Abstract][Full Text] [Related]
23. Effect of troglitazone (CS-045) and bezafibrate on glucose tolerance, liver glycogen synthase activity, and beta-oxidation in fructose-fed rats.
Inoue I; Takahashi K; Katayama S; Harada Y; Negishi K; Itabashi A; Ishii J
Metabolism; 1995 Dec; 44(12):1626-30. PubMed ID: 8786734
[TBL] [Abstract][Full Text] [Related]
24. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM
Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745
[TBL] [Abstract][Full Text] [Related]
25. Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts.
Kellerer M; Kroder G; Tippmer S; Berti L; Kiehn R; Mosthaf L; Häring H
Diabetes; 1994 Mar; 43(3):447-53. PubMed ID: 7508875
[TBL] [Abstract][Full Text] [Related]
26. Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats.
Isshiki K; Haneda M; Koya D; Maeda S; Sugimoto T; Kikkawa R
Diabetes; 2000 Jun; 49(6):1022-32. PubMed ID: 10866056
[TBL] [Abstract][Full Text] [Related]
27. Effect of troglitazone on vascular and glucose metabolic actions of insulin in high-sucrose-fed rats.
Santuré M; Pitre M; Nadeau A; Bachelard H
Metabolism; 2003 Aug; 52(8):978-86. PubMed ID: 12898461
[TBL] [Abstract][Full Text] [Related]
28. Troglitazone (CS-045) normalizes hypertriglyceridemia and restores the altered patterns of glucose-stimulated insulin secretion in dyslipidemic rats.
Chicco A; Basabe JC; Karabatas L; Ferraris N; Fortino A; Lombardo YB
Metabolism; 2000 Oct; 49(10):1346-51. PubMed ID: 11079827
[TBL] [Abstract][Full Text] [Related]
29. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
[TBL] [Abstract][Full Text] [Related]
30. Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes.
Tafuri SR
Endocrinology; 1996 Nov; 137(11):4706-12. PubMed ID: 8895337
[TBL] [Abstract][Full Text] [Related]
31. Tolbutamide enhances insulin action on gluconeogenesis and on fructose 2,6-bisphosphate levels in isolated rat hepatocytes.
Monge L; Cabello MA; Samper B; Mojena M; Felíu JE
Diabete Metab; 1988 Dec; 14(6):712-6. PubMed ID: 2977593
[TBL] [Abstract][Full Text] [Related]
32. Decreased responsiveness of gluconeogenesis to the modulation by sulfonylureas in hepatocytes isolated from obese (fa/fa) Zucker rats.
Lechuga CG; Carrillo JJ; Sánchez-Gutiérrez JC; Felíu JE
Life Sci; 2001 Feb; 68(14):1617-28. PubMed ID: 11263674
[TBL] [Abstract][Full Text] [Related]
33. The permissive effects of glucocorticoid on hepatic gluconeogenesis. Glucagon stimulation of glucose-suppressed gluconeogenesis and inhibition of 6-phosphofructo-1-kinase in hepatocytes from fasted rats.
Chan TM
J Biol Chem; 1984 Jun; 259(12):7426-32. PubMed ID: 6234302
[TBL] [Abstract][Full Text] [Related]
34. Unique ability of troglitazone to up-regulate peroxisome proliferator-activated receptor-gamma expression in hepatocytes.
Davies GF; McFie PJ; Khandelwal RL; Roesler WJ
J Pharmacol Exp Ther; 2002 Jan; 300(1):72-7. PubMed ID: 11752099
[TBL] [Abstract][Full Text] [Related]
35. Effect of thiazolidinediones on bile acid transport in rat liver.
Snow KL; Moseley RH
Life Sci; 2007 Jan; 80(8):732-40. PubMed ID: 17126857
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanism.
Davies GF; Khandelwal RL; Wu L; Juurlink BH; Roesler WJ
Biochem Pharmacol; 2001 Oct; 62(8):1071-9. PubMed ID: 11597575
[TBL] [Abstract][Full Text] [Related]
37. Acute exposure of beta-cells to troglitazone decreases insulin hypersecretion via activating AMPK.
Deng R; Nie A; Jian F; Liu Y; Tang H; Zhang J; Zhang Y; Shao L; Li F; Zhou L; Wang X; Ning G
Biochim Biophys Acta; 2014 Jan; 1840(1):577-85. PubMed ID: 24144566
[TBL] [Abstract][Full Text] [Related]
38. Decreased responsiveness of basal gluconeogenesis to insulin action in hepatocytes isolated from genetically obese (fa/fa) Zucker rats.
Sánchez-Gutiérrez JC; Sánchez-Arias JA; Lechuga CG; Valle JC; Samper B; Felíu JE
Endocrinology; 1994 Apr; 134(4):1868-73. PubMed ID: 8137754
[TBL] [Abstract][Full Text] [Related]
39. Impairment of the modulation by glucose of hepatic gluconeogenesis in the genetically obese (fa/fa) Zucker rat.
Sánchez-Gutiérrez JC; Lechuga CG; Sánchez-Arias JA; Samper B; Felíu JE
Endocrinology; 1995 May; 136(5):1877-84. PubMed ID: 7720633
[TBL] [Abstract][Full Text] [Related]
40. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.
Law RE; Meehan WP; Xi XP; Graf K; Wuthrich DA; Coats W; Faxon D; Hsueh WA
J Clin Invest; 1996 Oct; 98(8):1897-905. PubMed ID: 8878442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
